Literature DB >> 6208680

Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities.

R S Daniels, A R Douglas, J J Skehel, D C Wiley, C W Naeve, R G Webster, G N Rogers, J C Paulson.   

Abstract

Monoclonal antibodies were used to compare the antigenicities of the haemagglutinins of two receptor binding mutants of X-31 (H3N2) influenza virus. The mutants which differed from each other in recognizing sialic acid in either alpha 2-6 linkage or alpha 2-3 linkage to galactose also differed exclusively at residue 226 of the HA1 polypeptides of their haemagglutinins (G. N. Rogers, J. C. Paulson, R. S. Daniels, J. J. Skehel, I. A. Wilson, and D. C. Wiley, Nature (London) 304, 76-78, 1983). The results obtained indicate that whereas the majority of antihaemagglutinin monoclonal antibodies react with both mutants equally well, a number which specifically recognize residues 193, 199, 219, and 229 of HA1 of the alpha 2-6 linkage-binding mutant fail to recognize the alpha 2-3 linkage-binding haemagglutinins. The results are discussed with reference to the three-dimensional structure of the haemagglutinin and in relation to differences in antigenicity observed in the haemagglutinins of viruses grown in cells of different types.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208680     DOI: 10.1016/0042-6822(84)90158-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations.

Authors:  J X Zhang; I Braakman; K E Matlack; A Helenius
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

2.  Colloquium paper: uniquely human evolution of sialic acid genetics and biology.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

3.  Analysis of antigenic determinants on internal and external proteins of influenza virus and identification of antigenic subpopulations of virions in recent field isolates using monoclonal antibodies and immunogold labelling.

Authors:  S Patterson; J S Oxford
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus.

Authors:  P A Underwood; J J Skehel; D C Wiley
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  Single-amino-acid substitution in an antigenic site of influenza virus hemagglutinin can alter the specificity of binding to cell membrane-associated gangliosides.

Authors:  Y Suzuki; H Kato; C W Naeve; R G Webster
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Phenotypic expression of HA-NA combinations in human-avian influenza A virus reassortants.

Authors:  I A Rudneva; E I Sklyanskaya; O S Barulina; S S Yamnikova; V P Kovaleva; I V Tsvetkova; N V Kaverin
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Antigenic heterogeneity within influenza A (H3N2) virus strains.

Authors:  J C de Jong; F M de Ronde-Verloop; T M Veenendaal-van Herk; T F Weijers; K Bijlsma; A D Osterhaus
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 8.  H5N1 receptor specificity as a factor in pandemic risk.

Authors:  James C Paulson; Robert P de Vries
Journal:  Virus Res       Date:  2013-04-22       Impact factor: 3.303

9.  Molecular characterization and phylogenetic analysis of H3N2 human influenza A viruses in Cheongju, South Korea.

Authors:  Yun Hee Baek; Jeung Hyun Park; Young Jun Song; Min-Suk Song; Philippe Noriel Q Pascua; Yoon-Soo Hahn; Heon-Seok Han; Ok-Jun Lee; Ki-Soon Kim; Chun Kang; Young-Ki Choi
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

10.  Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918.

Authors:  Jun Shen; Jianpeng Ma; Qinghua Wang
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.